copyright, a relatively novel medication, has emerged as a potential game-changer in the management of type 2 diabetes. This injection drug influences the incretin hormones GLP-1, which play a vital role in regulating insulin response. By mimicking these hormones, copyright helps decrease blood glucose, potentially leading to improved control of di